| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 136,566 | 133,290 | 133,192 | 132,278 | | Cost of Revenue | 27,115 | 26,825 | 33,847 | 48,267 | | | Gross Profit |
-
| 106,465 | 99,345 | 84,011 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 54,542 | 63,670 | 57,728 | 54,635 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 89,578 | 22,831 | 18,134 | 119,518 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 19,964 | 23,483 | (90,142) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (36,415) | 19,964 | 23,483 | (90,195) | | Interest Expense | 10,118 | 10,658 | 11,903 | 13,187 | | Income Before Tax | (46,533) | 9,306 | 11,580 | (103,382) | | Income Tax Expense | (18,789) | 3,372 | 4,409 | (40,769) | | Minority Interest |
-
| 60 | (60) | (53) | | | | Net Income From Continuing Ops | (27,927) | 5,994 | 7,111 | (62,613) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (27,927) | 5,994 | 7,111 | (62,613) | | Preferred Stock And Other Adjustments | (3,268) | (3,516) | (2,270) | (146) | | | Net Income Applicable To Common Shares | ($31,195) | $2,478 | $4,841 | ($62,759) |
|
0.51% Nasdaq 
Income Statement
